Featured Research

from universities, journals, and other organizations

Awareness Of Epidemiology's Limitations Could Reduce Impact Of False-positive Cancer Results

Date:
July 8, 2008
Source:
Journal of the National Cancer Institute
Summary:
False-positive results are an inherent risk in cancer research, particularly in observational studies. The frequency and impact of misleading results can be mitigated if researchers use more exacting standards when interpreting and reporting results, according to a new commentary. Additionally, the impact of false-positive results could be lessened if the researchers and other stakeholders -- journal editors, the media and consumers -- evaluated the results with a more critical eye.

False-positive results are an inherent risk in cancer research, particularly in observational epidemiology studies. The frequency and impact of misleading results can be mitigated if researchers use more exacting standards when interpreting and reporting results, according to a recent commentary. Additionally, the impact of false-positive results could be lessened if the researchers and other stakeholders, including journal editors, the media, and consumers, evaluated the results with a more critical eye.

In the commentary, Paolo Boffetta, M.D., of the International Agency for Research on Cancer in Lyon, France, and other senior researchers from Vanderbilt University in Nashville, Tenn., and the Mario Negri Institute in Milan, Italy, discuss some of the key pitfalls of epidemiological research. For example, the authors describe what has happened over the last decade and a half after one small study reported an apparently strong association between pesticide residues in women's blood and the risk of breast cancer.

Since then, seven more studies have examined the association, and successive meta-analyses that incorporated the accumulating data showed a decreasing relative risk from a more than four-fold increased risk to no increased risk. That pattern of decreasing summary risk indicates that the initial observation was incorrect.

Common problems that can lead to the occurrence and reporting of false positives include chance, systematic errors in the design or analysis of a study that introduce various types of biases, inadequate accounting for confounding variables, multiple subgroup analyses, and a preference amongst authors and editors to report positive, novel, or statistically significant results rather than results that suggest no association. Although researchers and readers may think these factors have a relatively small impact on the outcome of a study, the authors note that a previous analysis demonstrated that unmeasured and residual confounding could generate up to a 2-fold apparent increase in risk, even though the variable being examined did not have any real risk associated with it.

For each of these issues, the authors suggest ways to mitigate the problem. For example, they suggest that researchers should not give undue emphasis to the results of post-hoc and subgroup analyses or emphasize outcomes of borderline statistical significance. "Epidemiologists by training are most often aware of the methodological limitations of observational studies, particularly those done by others, yet when it comes to practice, and especially the interpretation of their own study results, methodological vigilance is often absent," the authors write.

Moreover, both researchers and readers should view novel results critically. "One of the simplest yet potentially most effective remedies involves increasing emphasis on skepticism when assessing study results, particularly when they are new."


Story Source:

The above story is based on materials provided by Journal of the National Cancer Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Boffetta P, McLaughlin JK, La Vecchia C, Tarone RE, Lipworth L, Blot WJ. False-Positive Results in Cancer Epidemiology: A Plea for Epistemological Modesty. Journal of the National Cancer Institute, July 8, 2008, 100:988-995

Cite This Page:

Journal of the National Cancer Institute. "Awareness Of Epidemiology's Limitations Could Reduce Impact Of False-positive Cancer Results." ScienceDaily. ScienceDaily, 8 July 2008. <www.sciencedaily.com/releases/2008/07/080708161216.htm>.
Journal of the National Cancer Institute. (2008, July 8). Awareness Of Epidemiology's Limitations Could Reduce Impact Of False-positive Cancer Results. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/07/080708161216.htm
Journal of the National Cancer Institute. "Awareness Of Epidemiology's Limitations Could Reduce Impact Of False-positive Cancer Results." ScienceDaily. www.sciencedaily.com/releases/2008/07/080708161216.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins